Public Plans
Public plans are plans created using the DMP Tool service and shared publicly by their owners. They are not vetted for quality, completeness, or adherence to funder guidelines.
Plans (88)
NIH-Default DMSP
Automated and Segmentation-Optional Approaches for Extracting and Characterizing Clinically-Predictive Patterns of Immune Cell Organization from Multi-Sample Imaging Mass Cytometry Datasets
First Last, University of North Carolina at Chapel Hill (UNC-CH) (unc.edu)
NIH-Default DMSP
Regulation of Zn2+ translocation through the mitochondrial Ca2+ uniporter (MCU) and ischemic brain injury
John Weiss, University of California, Irvine
NIH-Default DMSP
cAMP and biofilm formation
George O'toole, Dartmouth College (dartmouth.edu)
NIH-Default DMSP
Disparities in Substance Use and Mental Health for Women by Sexual Orientation: Identifying Modifiable Risk and Protective Factors during the COVID-19 Pandemic Using Multiple Sources of Health Data
Kristie Seelman, Georgia State University (gsu.edu)
NIH-Default DMSP
The study and improvement of data collection and management for infectious diseases and immunodeficiencies
Emily Ricotta, National Institutes of Health (nih.gov)
NIH-Default DMSP
IRF3 and macrophage polarization during experimental periodontitis
Tom Petro, University of Nebraska Medical Center (unmc.edu)
NIH-Default DMSP
Transcriptional Dysregulation in the Pathogenesis of NAFLD
Baran Ersoy, Weill Cornell Medicine
NIH-Default DMSP
Racial Equity Tools to Prevent Youth Violence and to Reduce Racially Inequitable Youth Outcomes (Racial Equity Project, REP) in Worcester, MA.
Laurie Ross, Clark University (clarku.edu)
NIH-Default DMSP
Signature for Pain Recovery IN Teens (SPRINT)
Emma Biggs, Stanford University (stanford.edu)
NIH-GEN: Generic (Current until 2023)
Blocking the long noncoding RNA, INCR1, with an antisense oligonucleotide (ASO) to reverse GBM immuno-evasion”
E.antonio Chiocca, PSC Partners Seeking a Cure (pscpartners.org)
